BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sherry AD, Msaouel P, McCaw ZR, et al. (2023) Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. European Journal of Cancer (Oxford, England : 1990). 194: 113357 |
| Rooney MK, Sharifi B, Ludmir EB, et al. (2023) Factors Associated With Altmetric Attention Scores for Randomized Phase III Cancer Clinical Trials. Jco Clinical Cancer Informatics. 7: e2300082 |
| Sherry AD, Corrigan KL, Kouzy R, et al. (2023) Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer |
| Florez MA, Jaoude JA, Patel RR, et al. (2023) Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. Jama Network Open. 6: e2313819 |
| Das A, Lin TA, Lin C, et al. (2023) Assessment of Median and Mean Survival Time in Cancer Clinical Trials. Jama Network Open. 6: e236498 |
| Corrigan KL, Kouzy R, Jaoude JA, et al. (2022) Inclusion of premenopausal women in breast cancer clinical trials. Breast (Edinburgh, Scotland). 66: 204-207 |
| Diefenhardt M, Martin D, Ludmir EB, et al. (2022) Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers. 14 |
| Koay EJ, Zaid M, Aliru M, et al. (2022) Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. International Journal of Radiation Oncology, Biology, Physics |
| Bumanlag IM, Jaoude JA, Rooney MK, et al. (2022) Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations. Seminars in Radiation Oncology. 32: 125-134 |
| Patel RR, Parisi R, Verma V, et al. (2022) Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers. 14 |